Skip to main content

Correction to: Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo efects of LenabasumTM

The Original Article was published on 04 January 2022

Correction to: Arthritis Res Ther 24, 12 (2022)

https://doi.org/10.1186/s13075-021-02665-x

Following publication of the original article [1], the authors identified an error in Fig. 3. The correct figure is given below.

Fig. 3
figure 1

CB2R distribution among DM skin and DM PBMCs via flow cytometry. DM and HC peripheral blood PBMCs and skin cells isolated and stained via flow cytometry. a Percentage of CB2R expression in CD4+ T cells, CD11c+ mDCs, and CD123+ pDCs compared between DM peripheral blood and skin. b CB2R expression in skin and peripheral blood samples of a single patient shown with respect to CD4+ T cells, CD11c+ mDCs, and CD123+ pDCs. Graph shows the median. ***p<0.001. DM, dermatomyositis; HC, healthy control; mDC, myeloid dendritic cells; PBMC, peripheral blood mononuclear cell; pDC, plasmacytoid dendritic cell

The original article [1] has been updated.

Reference

  1. Maddukuri S, Patel J, Diaz DA, et al. Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of LenabasumTM. Arthritis Res Ther. 2022;24:12. https://doi.org/10.1186/s13075-021-02665-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Victoria P. Werth.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Maddukuri, S., Patel, J., Diaz, D.A. et al. Correction to: Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo efects of LenabasumTM. Arthritis Res Ther 24, 69 (2022). https://doi.org/10.1186/s13075-022-02758-1

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13075-022-02758-1